<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Schreiner AD</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><pagination>917-922</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11096263</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>58(9)</volume><pubmed_abstract>&lt;h4>Background and goals&lt;/h4>The Fibrosis-4 Index (FIB-4) has demonstrated a strong association with severe liver disease (SLD) outcomes in primary care, but previous studies have only evaluated this relationship using 1 or 2 FIB-4 scores. In this study, we determined the association of FIB-4 as a time-varying covariate with SLD risk using time-dependent Cox regression models.&lt;h4>Study&lt;/h4>This retrospective cohort study included primary care patients with at least 2 FIB-4 scores between 2012 and 2021. The outcome was the occurrence of an SLD event, a composite of cirrhosis, complications of cirrhosis, hepatocellular carcinoma, and liver transplantation. The primary predictor was FIB-4 advanced fibrosis risk, categorized as low-(&lt;1.3), indeterminate-(1.3≤FIB to 4&lt;2.67), and high-risk (≥2.67). FIB-4 scores were calculated and the index, last, and maximum FIB-4s were identified. Time-dependent Cox regression models were used to estimate hazard ratios (HR) and their corresponding 95% CI with adjustment for potentially confounding covariates.&lt;h4>Results&lt;/h4>In the cohort, 20,828 patients had a median of 5 (IQR: 3 to 11) FIB-4 scores each and 3% (n=667) suffered an SLD outcome during follow-up. Maximum FIB-4 scores were indeterminate-risk for 34% (7149) and high-risk for 24% (4971) of the sample, and 32% (6692) of patients had an increase in fibrosis risk category compared with their index value. The adjusted Cox regression model demonstrated an association between indeterminate- (hazard ratio 3.21; 95% CI 2.33-4.42) and high-risk (hazard ratio 20.36; 95% CI 15.03-27.57) FIB-4 scores with SLD outcomes.&lt;h4>Conclusions&lt;/h4>Multiple FIB-4 values per patient are accessible in primary care, FIB-4 fibrosis risk assessments change over time, and high-risk FIB-4 scores (≥2.67) are strongly associated with severe liver disease outcomes when accounting for FIB-4 as a time-varying variable.</pubmed_abstract><journal>Journal of clinical gastroenterology</journal><pubmed_title>FIB-4 as a Time-varying Covariate and Its Association With Severe Liver Disease in Primary Care: A Time-dependent Cox Regression Analysis.</pubmed_title><pmcid>PMC11096263</pmcid><funding_grant_id>UL1 TR001450</funding_grant_id><funding_grant_id>R03 DK129558</funding_grant_id><funding_grant_id>K23 DK118200</funding_grant_id><funding_grant_id>P30 DK123704</funding_grant_id><pubmed_authors>Schreiner AD</pubmed_authors><pubmed_authors>Livingston S</pubmed_authors><pubmed_authors>Bays C</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Mauldin PD</pubmed_authors><pubmed_authors>Marsden J</pubmed_authors><pubmed_authors>Koch DG</pubmed_authors><pubmed_authors>Moran WP</pubmed_authors><pubmed_authors>Gebregziabher M</pubmed_authors></additional><is_claimable>false</is_claimable><name>FIB-4 as a Time-varying Covariate and Its Association With Severe Liver Disease in Primary Care: A Time-dependent Cox Regression Analysis.</name><description>&lt;h4>Background and goals&lt;/h4>The Fibrosis-4 Index (FIB-4) has demonstrated a strong association with severe liver disease (SLD) outcomes in primary care, but previous studies have only evaluated this relationship using 1 or 2 FIB-4 scores. In this study, we determined the association of FIB-4 as a time-varying covariate with SLD risk using time-dependent Cox regression models.&lt;h4>Study&lt;/h4>This retrospective cohort study included primary care patients with at least 2 FIB-4 scores between 2012 and 2021. The outcome was the occurrence of an SLD event, a composite of cirrhosis, complications of cirrhosis, hepatocellular carcinoma, and liver transplantation. The primary predictor was FIB-4 advanced fibrosis risk, categorized as low-(&lt;1.3), indeterminate-(1.3≤FIB to 4&lt;2.67), and high-risk (≥2.67). FIB-4 scores were calculated and the index, last, and maximum FIB-4s were identified. Time-dependent Cox regression models were used to estimate hazard ratios (HR) and their corresponding 95% CI with adjustment for potentially confounding covariates.&lt;h4>Results&lt;/h4>In the cohort, 20,828 patients had a median of 5 (IQR: 3 to 11) FIB-4 scores each and 3% (n=667) suffered an SLD outcome during follow-up. Maximum FIB-4 scores were indeterminate-risk for 34% (7149) and high-risk for 24% (4971) of the sample, and 32% (6692) of patients had an increase in fibrosis risk category compared with their index value. The adjusted Cox regression model demonstrated an association between indeterminate- (hazard ratio 3.21; 95% CI 2.33-4.42) and high-risk (hazard ratio 20.36; 95% CI 15.03-27.57) FIB-4 scores with SLD outcomes.&lt;h4>Conclusions&lt;/h4>Multiple FIB-4 values per patient are accessible in primary care, FIB-4 fibrosis risk assessments change over time, and high-risk FIB-4 scores (≥2.67) are strongly associated with severe liver disease outcomes when accounting for FIB-4 as a time-varying variable.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-06-03T23:29:41.571Z</modification><creation>2026-05-03T03:11:22.401Z</creation></dates><accession>S-EPMC11096263</accession><cross_references><pubmed>37983873</pubmed><doi>10.1097/MCG.0000000000001935</doi><doi>10.1097/mcg.0000000000001935</doi></cross_references></HashMap>